- Report
- February 2024
- 50 Pages
Global
From €1918EUR$2,160USD£1,674GBP
€2131EUR$2,400USD£1,860GBP
- Report
- February 2024
- 50 Pages
Global
From €1918EUR$2,160USD£1,674GBP
€2131EUR$2,400USD£1,860GBP
- Drug Pipelines
- August 2023
- 580 Pages
United States
From €3356EUR$3,780USD£2,930GBP
€3729EUR$4,200USD£3,255GBP
- Drug Pipelines
- May 2022
- 400 Pages
Global
From €2397EUR$2,700USD£2,093GBP
€2663EUR$3,000USD£2,325GBP
- Drug Pipelines
- March 2022
- 900 Pages
Global
From €7191EUR$8,100USD£6,278GBP
€7990EUR$9,000USD£6,975GBP
- Report
- October 2021
- 172 Pages
Global
From €1918EUR$2,160USD£1,674GBP
€2131EUR$2,400USD£1,860GBP
- Report
- December 2020
- 120 Pages
Global
From €1776EUR$2,000USD£1,550GBP
- Report
- June 2020
- 753 Pages
Global
From €2637EUR$2,970USD£2,302GBP
€2930EUR$3,300USD£2,558GBP
- Report
- November 2022
- 141 Pages
Global
From €4394EUR$4,950USD£3,836GBP
- Report
- January 2024
- 157 Pages
Global
From €4128EUR$4,650USD£3,604GBP
- Report
- November 2023
- 131 Pages
Global
From €4128EUR$4,650USD£3,604GBP
- Report
- August 2023
- 122 Pages
Global
From €4128EUR$4,650USD£3,604GBP
- Report
- August 2022
- 148 Pages
Global
From €4883EUR$5,500USD£4,263GBP
- Report
- December 2021
- 353 Pages
Global
From €4883EUR$5,500USD£4,263GBP
- Report
- September 2022
- 27 Pages
Global
From €1198EUR$1,350USD£1,046GBP
- Report
- July 2023
- 230 Pages
Global
From €2175EUR$2,450USD£1,899GBP
- Report
- March 2024
- 149 Pages
Global
From €4394EUR$4,950USD£3,836GBP
- Report
- February 2024
- 75 Pages
Europe
From €2619EUR$2,950USD£2,286GBP
- Report
- December 2022
- 153 Pages
Global
From €2330EUR$2,625USD£2,034GBP
€4661EUR$5,250USD£4,069GBP
- Report
- June 2022
- 257 Pages
Global
From €2330EUR$2,625USD£2,034GBP
€4661EUR$5,250USD£4,069GBP

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more